Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Virol Methods ; 301: 114453, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34990641

RESUMEN

Group A rotavirus (RVA) is a prevalent pathogen causing acute gastroenteritis (AGE) in young children and animals. We developed an in-house ELISA (ROTA-GeFeK) for RVA detection, based on the expression of native recombinant VP6 protein in E. coli. To detect the RVA antigen, rabbit polyclonal IgG antibodies, produced against rVP6,were used as capture and detector antibodies in a sandwich ELISA. To validate the ROTA-GeFeK, 252 stool samples from children with AGE, were evaluated by conventional RT-PCR and commercial ELISA. Compared to RT-PCR, the ROTAGeFeK had a sensitivity of 88.2 % and a specificity of 94.4 %. Total detection rates with the ROTA-GeFeK, commercial ELISA and RT-PCR were 58 %, 58 % and 64 % respectively. The limit of detection was equal to 2.1 × 10 4 CCID 50 of the RVA strain RIX4414. No cross-reactivity with other enteric pathogens was observed. The RVApositive samples detected by the assay belonged to a diversity of G and [P] genotypes.This assay displayed reactivity and was proved to be useful for the detection of RVA in diarrheal samples of domestic South American Camelids. We suggest that the ROTAGeFeK can be used as an epidemiologic tool for rotavirus surveillance and for RVA detection in other animal species.


Asunto(s)
Infecciones por Rotavirus , Rotavirus , Animales , Preescolar , Diarrea/diagnóstico , Diarrea/veterinaria , Ensayo de Inmunoadsorción Enzimática , Escherichia coli , Heces , Genotipo , Humanos , Filogenia , Conejos , Rotavirus/genética , Infecciones por Rotavirus/diagnóstico , Infecciones por Rotavirus/veterinaria , América del Sur
2.
Mol Biochem Parasitol ; 176(2): 80-9, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21241743

RESUMEN

Juv-p120 is an excretory-secretory 160 kDa glycoprotein of juvenile female Litomosoides sigmodontis and exhibits features typical for mucins. 50% of its molecular mass is attributed to posttranslational modifications with the unusual substituent dimethylaminoethanol (DMAE). By that Juv-p120 corresponds to the surface proteins of the microfilarial sheath, Shp3 and Shp3a. The secreted protein consists of 697 amino acids, organized in two different domains of repeat elements separated by a stretch of polar residues. The N-terminal domain shows fourteen P/S/T/F-rich repeat elements highly modified with phospho-DMAE substituted O-glycans confering a negative charge to the protein. The C-terminal domain is extremely rich in glutamine (35%) and leucine (25%) in less organized repeats and may play a role in oligomerization of Juv-p120 monomers. A protein family with a similar Q/L-rich region and conserved core promoter region was identified in Brugia malayi by homology screening and in Wuchereria bancrofti and Loa loa by database similarity search. One of the Q/L-rich proteins in each genus has an extended S/T-rich region and due to this feature is supposed to be a putative Juv-p120 ortholog. The corresponding modification of Juv-p120 and the microfilarial sheath surface antigens Shp3/3a explains the appearance of anti-sheath antibodies before the release of microfilariae. The function of Juv-p120 is unknown.


Asunto(s)
Antígenos Helmínticos/genética , Deanol/metabolismo , Filarioidea/química , Proteínas de la Membrana/genética , Microfilarias/química , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Aminoácidos/genética , Aminoácidos/metabolismo , Animales , Anticuerpos Antihelmínticos/inmunología , Antígenos Helmínticos/inmunología , Antígenos Helmínticos/metabolismo , Brugia Malayi , Deanol/química , Femenino , Filariasis/genética , Filariasis/inmunología , Filariasis/metabolismo , Filarioidea/genética , Filarioidea/inmunología , Filarioidea/metabolismo , Loa , Proteínas de la Membrana/inmunología , Proteínas de la Membrana/metabolismo , Microfilarias/genética , Microfilarias/inmunología , Microfilarias/metabolismo , Datos de Secuencia Molecular , Peso Molecular , Murinae , Procesamiento Proteico-Postraduccional , Homología de Secuencia , Wuchereria bancrofti
3.
Clin Vaccine Immunol ; 17(10): 1598-604, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20668136

RESUMEN

Many proteins of Trypanosoma cruzi, the causative agent of Chagas' disease, contain characteristic arrays of highly repetitive immunogenic amino acid motifs. Diagnostic tests using these motifs in monomeric or dimeric form have proven to provide markedly improved specificity compared to conventional tests based on crude parasite extracts. However, in many cases the available tests still suffer from limited sensitivity. In this study we produced stable synthetic genes with maximal codon variability for the four diagnostic antigens, B13, CRA, TcD, and TcE, each containing between three and nine identical amino acid repeats. These genes were combined by linker sequences encoding short proline-rich peptides, giving rise to a 24-kDa fusion protein which was used as a novel diagnostic antigen in an enzyme-linked immunosorbent assay setup. Validation of the assay with a large number of well-characterized patient sera from Bolivia and Brazil revealed excellent diagnostic performance. The high sensitivity of the new test may allow future studies to use blood collected by finger prick and dried on filter paper, thus dramatically reducing the costs and effort for the detection of T. cruzi infection.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Antígenos de Protozoos , Enfermedad de Chagas/diagnóstico , Parasitología/métodos , Trypanosoma cruzi/inmunología , Antígenos de Protozoos/genética , Bolivia , Brasil , ADN Protozoario/química , ADN Protozoario/genética , Ensayo de Inmunoadsorción Enzimática/métodos , Humanos , Datos de Secuencia Molecular , Proteínas Recombinantes de Fusión/genética , Sensibilidad y Especificidad , Análisis de Secuencia de ADN , Pruebas Serológicas/métodos
4.
FEBS Lett ; 579(28): 6433-8, 2005 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-16289098

RESUMEN

In the malaria parasite Plasmodium falciparum isoprenoid precursors are synthesised inside a plastid-like organelle (apicoplast) by the mevalonate independent 1-deoxy-d-xylulose-5-phosphate (DOXP) pathway. The last reaction step of the DOXP pathway is catalysed by the LytB enzyme which contains a [4Fe-4S] cluster. In this study, LytB of P. falciparum was shown to be catalytically active in the presence of an NADPH dependent electron transfer system comprising ferredoxin and ferredoxin-NADP(+) reductase. LytB and ferredoxin were found to form a stable protein complex. These data suggest that the ferredoxin/ferredoxin-NADP(+) reductase redox system serves as the physiological electron donor for LytB in the apicoplast of P. falciparum.


Asunto(s)
Ferredoxina-NADP Reductasa/metabolismo , Ferredoxinas/metabolismo , Plasmodium falciparum/enzimología , Proteínas Protozoarias/metabolismo , Terpenos/metabolismo , Animales , Catálisis , Transporte de Electrón , NADP/metabolismo , Oxidación-Reducción , Paraquat/química , Proteínas Protozoarias/genética , Proteínas Recombinantes/genética
5.
Arch Pharm (Weinheim) ; 338(7): 305-14, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15996004

RESUMEN

FR900098 represents a derivative of the new antimalarial drug fosmidomycin with enhanced activity. The mechanism of action is the inhibition of the 1-desoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase, an essential enzyme of the mevalonate independent pathway of isoprenoid biosynthesis. Prodrugs with increased oral activity in mice infected with the rodent malaria parasite Plasmodium vinckei were obtained by masking the phosphonate moiety of FR900098 as alkoxycarbonyloxyethyl esters.


Asunto(s)
Antimaláricos/uso terapéutico , Fosfomicina/análogos & derivados , Malaria/prevención & control , Profármacos/uso terapéutico , Administración Oral , Isomerasas Aldosa-Cetosa/antagonistas & inhibidores , Isomerasas Aldosa-Cetosa/metabolismo , Animales , Antimaláricos/síntesis química , Antimaláricos/farmacocinética , Disponibilidad Biológica , Relación Dosis-Respuesta a Droga , Fosfomicina/sangre , Fosfomicina/síntesis química , Fosfomicina/farmacocinética , Fosfomicina/uso terapéutico , Malaria/parasitología , Ratones , Ratones Endogámicos BALB C , Complejos Multienzimáticos/antagonistas & inhibidores , Complejos Multienzimáticos/metabolismo , Oxidorreductasas/antagonistas & inhibidores , Oxidorreductasas/metabolismo , Plasmodium/efectos de los fármacos , Profármacos/síntesis química , Profármacos/farmacocinética , Relación Estructura-Actividad Cuantitativa
6.
Infect Immun ; 72(8): 4881-3, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15271953

RESUMEN

While most mycoplasma species appear to have evolutionarily lost the ability to synthesize isoprenoid precursors, Mycoplasma penetrans has retained the nonmevalonate pathway that proceeds via the immunogenic intermediate (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP). Consequently, this pathogen is capable of stimulating human V gamma 9/V delta 2 T cells.


Asunto(s)
Difosfatos/inmunología , Eritritol/análogos & derivados , Activación de Linfocitos/inmunología , Mycoplasma penetrans/inmunología , Receptores de Antígenos de Linfocitos T gamma-delta/metabolismo , Linfocitos T/inmunología , Animales , Difosfatos/metabolismo , Eritritol/metabolismo , Humanos , Mycoplasma/inmunología , Mycoplasma/metabolismo , Mycoplasma penetrans/genética , Fosfatos de Azúcar/metabolismo , Terpenos/metabolismo
7.
Bioorg Med Chem Lett ; 13(13): 2163-6, 2003 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-12798327

RESUMEN

FR900098 represents an improved derivative of the new antimalarial drug fosmidomycin and acts through inhibition of the 1-deoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase, an essential enzyme of the mevalonate independent pathway of isoprenoid biosynthesis. Prodrugs with increased activity after oral administration were obtained by chemical modification of the phosphonate moiety to yield acyloxyalkyl esters. The most successful compound demonstrated 2-fold increased activity in mice infected with the rodent malaria parasite Plasmodium vinckei.


Asunto(s)
Antimaláricos/síntesis química , Antimaláricos/farmacología , Fosfomicina/análogos & derivados , Fosfomicina/síntesis química , Fosfomicina/farmacología , Profármacos/síntesis química , Profármacos/farmacología , Animales , Antimaláricos/farmacocinética , Disponibilidad Biológica , Fosfomicina/farmacocinética , Indicadores y Reactivos , Lisofosfolípidos/metabolismo , Malaria/tratamiento farmacológico , Malaria/parasitología , Ácido Mevalónico/metabolismo , Ratones , Ratones Endogámicos BALB C , Profármacos/farmacocinética
8.
FEBS Lett ; 532(3): 432-6, 2002 Dec 18.
Artículo en Inglés | MEDLINE | ID: mdl-12482607

RESUMEN

The gcpE gene product controls one of the terminal steps of isoprenoid biosynthesis via the mevalonate independent 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway. This pathway is utilized by a variety of eubacteria, the plastids of algae and higher plants, and the plastid-like organelle of malaria parasites. Recombinant GcpE protein from the hyperthermophilic bacterium Thermus thermophilus was produced in Escherichia coli and purified under dioxygen-free conditions. The protein was enzymatically active in converting 2-C-methyl-D-erythritol-2,4-cyclodiphosphate (MEcPP) into (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) in the presence of dithionite as reductant. The maximal specific activity was 0.6 micromol x min(-1) x mg(-1) at pH 7.5 and 55 degrees C. The kcat value was 0.4 s(-1) and the K(m) value for HMBPP 0.42 mM.


Asunto(s)
Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Enzimas , Fosfatos de Poliisoprenilo/biosíntesis , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Escherichia coli/metabolismo , Cinética , Luz , Activación de Linfocitos , Modelos Químicos , Datos de Secuencia Molecular , Organofosfatos/farmacología , Oxígeno/metabolismo , Plásmidos/metabolismo , Plastidios/metabolismo , Pirimidinas/farmacología , Proteínas Recombinantes/metabolismo , Espectrometría de Masa por Ionización de Electrospray , Linfocitos T/metabolismo , Thermus thermophilus/metabolismo , Rayos Ultravioleta
9.
FEBS Lett ; 532(3): 437-40, 2002 Dec 18.
Artículo en Inglés | MEDLINE | ID: mdl-12482608

RESUMEN

Recombinant LytB protein from the thermophilic eubacterium Aquifex aeolicus produced in Escherichia coli was purified to apparent homogeneity. The purified LytB protein catalyzed the reduction of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) in a defined in vitro system. The reaction products were identified as isopentenyl diphosphate and dimethylallyl diphosphate. A spectrophotometric assay was established to determine the steady-state kinetic parameters of LytB protein. The maximal specific activity of 6.6+/-0.3 micromol x min(-1) x mg(-1) protein was determined at pH 7.5 and 60 degrees C. The k(cat) value of the LytB protein was 3.7+/-0.2 s(-1) and the K(m) value for HMBPP was 590+/-60 microM.


Asunto(s)
Proteínas Bacterianas/fisiología , Eritritol/análogos & derivados , Eritritol/metabolismo , Proteínas de Escherichia coli , Oxidorreductasas/fisiología , Fosfatos de Azúcar/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Catálisis , Cromatografía Líquida de Alta Presión , Clonación Molecular , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Escherichia coli/metabolismo , Eubacterium/genética , Eubacterium/metabolismo , Concentración de Iones de Hidrógeno , Cinética , Modelos Químicos , Datos de Secuencia Molecular , Organofosfatos/farmacología , Oxidorreductasas/genética , Oxidorreductasas/metabolismo , Unión Proteica , Estructura Terciaria de Proteína , Proteínas Recombinantes/metabolismo , Espectrometría de Masa por Ionización de Electrospray , Temperatura , Factores de Tiempo
10.
Cell Immunol ; 218(1-2): 1-6, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12470608

RESUMEN

Vgamma9/Vdelta2 T cells comprise a small population of peripheral T cells responding towards the low molecular weight antigen, (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate (HMB-PP). HMB-PP-stimulated Vgamma9/Vdelta2 T cells proliferated, expressed CCL5/RANTES, and upregulated markers like CD16, CD25, CD69, and CD94, in the presence of either IL-15 or IL-21. Vgamma9/Vdelta2 T cells grown in the presence of IL-15 differentiated into an effector/memory population characterized by production of TNF-alpha, expression of CD45RO and CCR5, and lack of CD62L, CD81, and CCR7. In contrast, Vgamma9/Vdelta2 T cells grown with IL-21 differentiated into putative central memory CD45RO(+) T cells that did not produce TNF-alpha, IFN-gamma, or IL-4, and maintained expression of CD62L, CD81, and CCR7.


Asunto(s)
Antígenos CD/biosíntesis , Memoria Inmunológica/inmunología , Interleucina-15/farmacología , Interleucinas/farmacología , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Subgrupos de Linfocitos T/inmunología , Diferenciación Celular/efectos de los fármacos , Células Cultivadas/citología , Células Cultivadas/inmunología , Quimiocina CCL5/biosíntesis , Difosfatos/inmunología , Citometría de Flujo , Regulación de la Expresión Génica/inmunología , Humanos , Mediadores de Inflamación/metabolismo , Lectinas Tipo C/biosíntesis , Subfamília D de Receptores Similares a Lectina de las Células NK , Receptores de IgG/biosíntesis , Subgrupos de Linfocitos T/citología
11.
J Physiol Paris ; 96(3-4): 329-38, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12445914

RESUMEN

We report here a partial characterization of a "tet-on" glia O2A precursor cell line established from the reverse tetracycline-transactivator (rtTA)-SV40 T antigen (Tag) double transgenic mice. In culture, withdrawal of doxycycline prevents proliferation and the cell line undergoes apoptosis. Importantly, differentiation into type-2-astrocytes and oligodendrocytes can be induced when the cell line is cultured, in the absence of doxycycline, and with epithelial stem cell lines secreting hIL3 or hIL6. In contrast, no maturation into progeny was observed when a hCNTF-secreting cell line was used as the co-culture partner under the same condition. In order to address the question of whether the morphological distinct cells-spindle and stellar shaped cells are of a similar or different cell types, we have performed cell size analysis of these cells by FACS and electro-physiology measurement by the patch clamping technique. They are of a similar cell size, but poses distinct electrophysiological properties-spindle cells are less mature than the stellar cells. These tet-on glia O2A precursor cells were implanted to sites of transected sciatic nerve of adult mice and kept in the precursor stage by feeding mice with doxycycline containing drinking water. The toe movement of injured foot was measured every 3 weeks and the electrophysiological property of motor neuron was determined three months after the operation. Preliminary data have shown that these tet-on glia precursor cells are not toxic to the implanted hosts and can enhance the recovery of damaged motor nerves.


Asunto(s)
Neuroglía/citología , Neuroglía/fisiología , Células Madre/citología , Células Madre/fisiología , Animales , Antígenos Transformadores de Poliomavirus/genética , Diferenciación Celular/fisiología , Línea Celular , Tamaño de la Célula , Técnicas de Cocultivo , Citometría de Flujo , Ratones , Ratones Transgénicos , Regeneración Nerviosa/fisiología , Técnicas de Placa-Clamp , Tetraciclina
12.
Antimicrob Agents Chemother ; 46(9): 2889-94, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12183243

RESUMEN

Fosmidomycin acts through inhibition of 1-deoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase, a key enzyme of the nonmevalonate pathway of isoprenoid biosynthesis. It possesses potent antimalarial activity in vitro and in murine malaria. In a recent clinical study, fosmidomycin was effective and well tolerated in the treatment of patients with acute uncomplicated Plasmodium falciparum malaria but resulted in an unacceptably high rate of recrudescence. In order to identify a potential combination partner, the interaction of fosmidomycin with a number of antimalarial drugs in current use was investigated in a series of in vitro experiments. Synergy was observed between fosmidomycin and the lincosamides, lincomycin and clindamycin. The efficacy of a combination of fosmidomycin and clindamycin was subsequently demonstrated in the Plasmodium vinckei mouse model.


Asunto(s)
Antibacterianos/farmacología , Antimaláricos/farmacología , Clindamicina/farmacología , Fosfomicina/análogos & derivados , Fosfomicina/farmacología , Plasmodium falciparum/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Humanos , Malaria/tratamiento farmacológico , Malaria/parasitología , Ratones
13.
Immunology ; 106(2): 200-11, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12047749

RESUMEN

Activation of human Vgamma9/Vdelta2 T cells by many pathogens depends on the presence of small phosphorylated non-peptide compounds derived from the 2-C-methyl-d-erythritol 4-phosphate (MEP) pathway of isoprenoid biosynthesis. We here demonstrate that in Escherichia coli mutants deficient in lytB, an essential gene of the MEP pathway, a potent Vgamma9/Vdelta2 T-cell activator accumulates by a factor of approximately 150 compared to wild-type E. coli. The compound responsible for the strong immunogenicity of this E. coli mutant was subsequently characterized and identified as a small pyrophosphorylated metabolite, with a molecular mass of 262 Da, derived from the MEP pathway. Stimulation of human peripheral blood mononuclear cells (PBMC) with extracts prepared from the lytB-deficient E. coli mutant led to upregulation of T-cell activation markers on the surface of Vgamma9/Vdelta2 T cells as well as proliferation and expansion of Vgamma9/Vdelta2 T cells. This response was dependent on costimulatory growth factors, such as interleukin (IL)-2, IL-15 and IL-21. Significant levels of interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) were secreted in the presence of IL-2 and IL-15, but not in the presence of IL-21, demonstrating that proliferating phosphoantigen-reactive Vgamma9/Vdelta2 T cells do not necessarily produce proinflammatory cytokines.


Asunto(s)
Proteínas Bacterianas/inmunología , Eritritol/análogos & derivados , Proteínas de Escherichia coli , Escherichia coli/inmunología , Activación de Linfocitos/inmunología , Oxidorreductasas , Receptores de Antígenos de Linfocitos T gamma-delta/análisis , Subgrupos de Linfocitos T/inmunología , Proteínas Bacterianas/genética , Factores Biológicos/inmunología , Factores Biológicos/aislamiento & purificación , División Celular/inmunología , Células Cultivadas , Cromatografía por Intercambio Iónico , Citocinas/biosíntesis , Eritritol/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Humanos , Interleucinas/inmunología , Peso Molecular , Fosfatos de Azúcar/metabolismo , Regulación hacia Arriba/inmunología
14.
J Biol Chem ; 277(7): 5378-84, 2002 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-11741911

RESUMEN

We have solved the 2.5-A crystal structure of 1-deoxy-D-xylulose-5-phosphate reductoisomerase, an enzyme involved in the mevalonate-independent 2-C-methyl-D-erythritol-4-phosphate pathway of isoprenoid biosynthesis. The structure reveals that the enzyme is present as a homodimer. Each monomer displays a V-like shape and is composed of an amino-terminal dinucleotide binding domain, a connective domain, and a carboxyl-terminal four-helix bundle domain. The connective domain is responsible for dimerization and harbors most of the active site. The strictly conserved acidic residues Asp(150), Glu(152), Glu(231), and Glu(234) are clustered at the putative active site and are probably involved in the binding of divalent cations mandatory for enzyme activity. The connective and four-helix bundle domains show significant mobility upon superposition of the dinucleotide binding domains of the three conformational states present in the asymmetric unit of the crystal. A still more pronounced flexibility is observed for a loop spanning residues 186 to 216, which adopts two completely different conformations within the three protein conformers. A possible involvement of this loop in an induced fit during substrate binding is discussed.


Asunto(s)
Isomerasas Aldosa-Cetosa/química , Complejos Multienzimáticos/química , Oxidorreductasas/química , Fosfatos de Poliisoprenilo/biosíntesis , Ácido Aspártico/química , Sitios de Unión , Cationes , Clonación Molecular , Cristalografía por Rayos X , Dimerización , Escherichia coli/enzimología , Ácido Glutámico/química , Ligandos , Modelos Químicos , Modelos Moleculares , Unión Proteica , Conformación Proteica , Estructura Cuaternaria de Proteína , Estructura Terciaria de Proteína
15.
J Gen Virol ; 82(Pt 4): 757-763, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11257179

RESUMEN

In the life-cycle of picornaviruses, the synthesis of the viral polyprotein is initiated cap-independently at the internal ribosome entry site (IRES) far downstream from the 5' end of the viral plus-strand RNA. The cis-acting IRES RNA elements serve as binding sites for translation initiation factors that guide the ribosomes to an internal site of the viral RNA. In this study, we show that the eukaryotic translation initiation factor eIF4G interacts directly with the IRES of foot-and-mouth disease virus (FMDV). eIF4G binds mainly to the large Y-shaped stem-loop 4 RNA structure in the 3' region of the FMDV IRES element, whereas stem-loop 5 contributes only slightly to eIF4G binding. Two subdomains of stem-loop 4 are absolutely essential for eIF4G binding, whereas another subdomain contributes to a lesser extent to binding of eIF4G. At the functional level, the translational activity of stem-loop 4 subdomain mutants correlates with the efficiency of binding of eIF4G in the UV cross-link assay. This indicates that the interaction of eIF4G with the IRES is crucial for the initiation of FMDV translation. A model for the interaction of initiation factors with the IRES element is discussed.


Asunto(s)
Aphthovirus/genética , Factores de Iniciación de Péptidos/metabolismo , ARN Viral/química , Ribosomas/metabolismo , Sitios de Unión , Factor 4G Eucariótico de Iniciación , Proteína de Unión al Tracto de Polipirimidina , Biosíntesis de Proteínas , Proteínas de Unión al ARN/fisiología , Ribonucleoproteínas/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA